Radiation Oncology/RTOG Trials/8519

RTOG 85-19 (PROSTATE)
 * Title: Phase II (title not available)
 * Objectives: (not available)
 * Protocol: (not available)
 * Eligibility: Bulky primary lesions, stage B2 and C, with disease confined to the pelvis
 * Enrolled: 31 patients
 * Conclusion:
 * PMID 2146872 -- Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy. (Pilepich MV, Am J Clin Oncol 1990). Conclusion: The observed toxicity appears acceptable and the response rate encouraging.